Bharat Biotech has given another great news about the Corona vaccine. In fact, the committee of experts of the country’s drug regulator Central Drugs Standard Control Organization (Central Drugs Standard Control Organization) has approved the first phase trial of the nasal corona vaccine, developed by Bharat Biotech. The company had recently written to the Controller General of Pharmaceuticals and sought approval for the first and second phase clinical trials (clinical trials) of the ‘nasal vaccine’. An official said that if this vaccine works, the fight against Corona will change significantly.

According to Bharat Biotech, initially, the nasal vaccine will be trialed in cities like Pune, Nagpur, Bhubaneswar, and Hyderabad. The company has already tied up for trial from a hospital in Nagpur. The most important thing about this vaccine is that this nasal vaccine is a single dose vaccine of Corona.

What vaccine is more effective?
According to scientists, research has found that a nasal vaccine is more effective than a vaccine injected over the shoulder. In September last year, researchers who created this vaccine claimed that this vaccine produces a more widespread immune response.

The indigenous vaccine will be supplied in six countries
The work of applying the Corona vaccine to the people in the country has already started and now Kovishield and Kovacine will be supplied to other countries from Wednesday. According to the Ministry of External Affairs, indigenous vaccines will be provided to Maldives, Bhutan, Bangladesh, Nepal, Myanmar, and Seychelles in aid.

How many people have been vaccinated in the country so far?
A total of 6.31 lakh people have been vaccinated in the country in four days. According to reports, 1,77,368 health workers were vaccinated till 6 pm on Tuesday. If we talk about the first day there, about two lakh people were given the first dose of the vaccine.